Glycemic variability in newly diagnosed diabetic cats treated with the glucagon-like peptide-1 analogue exenatide extended release.
Anna L KrämerAngelina RiedererFederico FracassiFelicitas S BorettiNadia S Sieber-RuckstuhlThomas A LutzBarbara ContieroEric ZiniClaudia E ReuschPublished in: Journal of veterinary internal medicine (2020)
The combination of EER, insulin, and a low-carbohydrate diet might be advantageous in the treatment of newly diagnosed diabetic cats.